Mersana Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Mersana Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2016 to Q2 2024.
  • Mersana Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 122M shares, a 5.91% increase year-over-year.
  • Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 116M shares, a 24% increase from 2022.
  • Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 93.7M shares, a 32.7% increase from 2021.
  • Mersana Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 70.6M shares, a 14.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 122M +6.83M +5.91% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 121M +13.9M +12.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 116M +22.5M +24% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 121M +22.9M +23.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 116M +19.9M +20.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 108M +27.6M +34.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 93.7M +23.1M +32.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 97.6M +25.9M +36.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 95.8M +26.1M +37.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 79.9M +10.9M +15.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 70.6M +9.1M +14.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 71.8M +3.33M +4.87% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 69.6M +8.87M +14.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 69M +21M +43.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 61.5M +13.6M +28.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 68.4M +20.6M +43% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 60.7M +13M +27.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 48M +17.7M +58.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 47.9M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 47.8M Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 47.7M +24.7M +108% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 30.3M +7.48M +32.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q2 2018 23M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 22.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2016 1.29M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 1.28M Jul 1, 2016 Sep 30, 2016 10-K 2018-03-28
Q2 2016 1.25M Apr 1, 2016 Jun 30, 2016 10-K 2018-03-28
Q1 2016 1.24M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.